Market Overview

According to fortune business insights, the global sleep disorder devices market size was valued at USD 23.28 billion in 2025. The market is projected to grow from USD 25.33 billion in 2026 to USD 44.40 billion by 2034, exhibiting a CAGR of 7.3% during the forecast period. North America dominated the sleep disorder devices market with a market share of 45.44% in 2025.

The analysis shows that major companies are investing more in sleep disorder devices as the prevalence of sleep diseases rises. For example, the increasing number of sleep studies and the development of healthcare systems are leading to a higher adoption rate. This trend indicates a strong demand for sleep disorder devices worldwide.

Major Players Profiled in the Market Report:

• Resmed (U.S.)
• Fisher & Paykel Healthcare Limited (New Zealand)
• Koninklijke Philips N.V. (Netherlands)
• Inspire Medical Systems, Inc. (U.S.)
• ZOLL Medical Corporation (U.S.)
• Compumedics Limited (Australia)
• Cadwell Industries Inc. (U.S.)
• React Health (U.S.)
• Löwenstein Medical SE & Co. KG (Germany)
• SomnoMed (Australia)

Segments

Increasing Cases of Sleep Disorders to Propel Therapeutics Segment Growth

Based on product type, the market is divided into diagnostic and therapeutic. The therapeutic segment holds the largest market share, driven by the increasing prevalence of sleep disorders, which results in a growing demand for therapeutic devices like CPAP machines.

High Prevalence of Sleep Disorders to Drive Adult Segment Expansion

By age group, the market is categorized into adults and pediatrics. The adults segment is leading the market due to the high prevalence of sleep disorders such as sleep apnea and insomnia within this demographic, leading to greater demand for both diagnostic and therapeutic products.

Growing Occurrence of Chronic Conditions to Drive Sleep Apnea Segment Dominance